市场调查报告书
商品编码
1451714
2024-2032 年按软体、服务(药物分析服务、护理点验证服务、药物不良事件监测服务)、交付方式、最终用户和地区分類的药物管理市场报告Medication Management Market Report by Software, Services (Medication Analytics Services, Point-Of-Care Verification Services, Adverse Drug Event Surveillance Services), Mode of Delivery, End User, and Region 2024-2032 |
2023年全球药物管理市场规模达30亿美元。展望未来, IMARC Group预计到2032年市场规模将达到58亿美元,2024-2032年复合年增长率(CAGR)为7.51%。
医疗管理包括监测、药物协调,以及透过设计治疗计划并监督其安全性和有效性来确保患者达到预期结果。作为该过程的一部分,患者及其照护者接受有关药物安全性和依从性以及药物不良事件的教育和参与。医疗改革中包含的药品管理系统加强了库存管理、药品配发和药品不良事件(ADE)的控制。此外,它还提供了对患者来说最舒适的提醒和组织工具,从而显着改善患者的治疗结果和安全性。正确利用药物管理服务可以降低疾病的盛行率和死亡率,从而使医疗保健更安全、更可靠。
该市场的主要推动力是医疗保健机构为改善工作流程和营运效率而进行的投资大幅增加。这可以归因于最大限度地减少用药错误和医疗保健支出的需求不断增加。除此之外,医疗保健提供者在有效管理和保存记录方面的工作量增加也为市场提供了动力。此外,透过在医疗保健领域使用新技术来实现工作流程管理解决方案自动化的趋势不断增长,这导致药物管理解决方案的采用率更高。容易受到多种健康状况影响的老年人口的增加进一步推动了市场的发展。除此之外,对基于价值的医学的更加关注正在为主要参与者创造利润丰厚的市场机会。其他影响市场的因素包括多种慢性疾病的日益普及、医疗技术的快速进步、重要的参与者併购(M&A)、不断增加的医疗保健支出以及广泛的研发(R&D)活动。
The global medication management market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7.51% during 2024-2032.
Medical management includes monitoring, medication reconciliation, and ensuring that patients achieve their desired results by designing treatment plans and supervising their safety and effectiveness. As part of the process, patients and their caregivers are educated and engaged about safety and adherence concerns about medications as well as adverse drug events. A medication management system, which is included in healthcare reform, enhances inventory management, dispensing of medicines, and the control of adverse drug events (ADE). Additionally, it suggests reminder and organization tools that are most comfortable for patients, leading to a significant improvement in both patient outcomes and safety. Utilizing medication management services correctly reduces the prevalence of disease and mortality rates, thereby making healthcare safer and more reliable.
The market is majorly driven by a considerable rise in investments by healthcare facilities to improve workflow and operational efficiency. This can be attributed to the escalating need to minimize medication errors and healthcare expenditures. In addition to this, the increased workload on healthcare providers for efficient management and preservation of the records is providing an impetus to the market. Moreover, the growing trend of automating workflow management solutions through the use of new technologies in the healthcare sector is resulting in a higher uptake of medication management solutions. The market is further propelled by the increasing geriatric population that is susceptible to numerous health conditions. Apart from this, an enhanced focus on value-based medicine is creating lucrative market opportunities for the key players. Some of the other factors contributing to the market include the growing prevalence of numerous chronic illnesses, rapid advancements in medical technology, significant player mergers and acquisitions (M&As), rising healthcare expenditure and extensive research and development (R&D) activities.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medication management market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on software, services, mode of delivery and end user.
Computerized Physician Order Entry System
Clinical Decision Support System
Administration Software
Electronic Medication Administration Record (EMAR) Software
Barcode Medication Administration (BMA) Software
Inventory Management System
Automated Dispensing Systems
Centralized Automated Dispensing Systems
Robots/Robotic Automated Dispensing Systems
Carousels
Decentralized Automated Dispensing Systems (Ads)
Pharmacy-Based Decentralized Automated Dispensing Systems
Ward-Based Decentralized Automated Dispensing Systems
Automated Unit-Dose Decentralized Automated Dispensing Systems
Assurance System
Medication Analytics Services
Point-Of-Care Verification Services
Adverse Drug Event (ADE) Surveillance Services
Web-based
Cloud-based
On-premises
Pharmacies
Hospitals
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allscripts Healthcare Solutions Inc., ARxIUM Inc., Becton Dickinson and Company, BIQ Health Solutions, Cardinal Health Inc., Mckesson Corporation, Omnicell Inc., Optum Inc. (UnitedHealth Group Incorporated), Oracle Corporation and Talyst LLC (Swisslog Healthcare). Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.